SCR-LIP-000477 · Claim · machine-readable JSON →

In a systematic review of six uncontrolled prospective trials (467 patients), tumescent liposuction was associated with statistically significant improvements in patient-reported pain at 6 months up to 12 years, reduced limb volume/circumference, and improved quality of life, with 17 postoperative adverse events (5 serious) across 492 patients, but all studies had moderate-to-high risk of bias and safety evidence was graded very low, so evidence is insufficient to prove liposuction is as safe and more effective than conservative treatment.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2021Tumescent liposuction for lipoedema: A systematic review of clinical effectiveness and safety (2021) · refining

Evidence (1)

Context (PECO)

Populationpatients with lipedema, stages I-III (467-492 patients)
Conditionlipedema
Exposuretumescent liposuction (any technique)
Comparatorconservative treatment
Outcomepain, limb volume/circumference, quality of life, adverse events
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log